CVS Health Corporation

Historical 13F Holders

Symbol
CVS
CUSIP
126650100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 126650100 since 12/18/2024, newest first.

Filer % of Class Filed
Dodge & Cox 13G/A Amendment 1 3.9% 8/13/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 7.5% 4/29/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 10 0% 3/26/2026
Event 3/13/2026
BlackRock, Inc. 13G/A Amendment 14 8.3% 7/16/2025
Event 6/30/2025
Capital World Investors 13G 5.5% 5/13/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 13 7.1% 4/17/2025
Event 3/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 93 4.53 M $388 M
2026 Q2 2,189 1.33 B $121 B
2026 Q1 1,988 1.11 B $79.4 B
2025 Q4 2,055 1.14 B $90.0 B
2025 Q3 1,949 1.13 B $85.2 B
2025 Q2 1,880 1.11 B $76.3 B
2025 Q1 1,870 1.09 B $73.6 B
2024 Q4 1,795 1.05 B $47.2 B
2024 Q3 1,954 1.04 B $65.4 B
2024 Q2 2,028 1.06 B $62.8 B
2024 Q1 2,295 1.08 B $85.8 B
2023 Q4 2,386 1.08 B $85.1 B
2023 Q3 2,223 1.00 B $70.5 B
2023 Q2 2,319 1.00 B $69.0 B
2023 Q1 2,394 1.02 B $74.8 B
2022 Q4 2,529 1.10 B $113 B
2022 Q3 2,442 1.04 B $99.8 B
2022 Q2 2,416 1.03 B $96.2 B
2022 Q1 2,477 1.03 B $105 B
2021 Q4 2,452 1.04 B $108 B
2021 Q3 2,189 1.02 B $87.2 B
2021 Q2 2,182 1.02 B $86.0 B
2021 Q1 2,147 997 M $75.6 B
2020 Q4 2,093 1.01 B $70.0 B
2020 Q3 1,920 999 M $58.8 B
2020 Q2 1,970 1.02 B $66.6 B
2020 Q1 1,924 1.01 B $60.3 B
2019 Q4 1,952 1.04 B $77.4 B
2019 Q3 1,800 1.02 B $64.2 B
2019 Q2 1,776 1.05 B $57.1 B
2019 Q1 1,826 1.02 B $55.1 B
2018 Q4 1,899 1.10 B $72.3 B
2018 Q3 1,714 910 M $71.6 B
2018 Q2 1,691 863 M $55.5 B
2018 Q1 1,646 866 M $53.9 B
2017 Q4 1,708 862 M $62.3 B
2017 Q3 1,622 840 M $68.3 B
2017 Q2 1,639 841 M $67.7 B
2017 Q1 1,687 856 M $67.2 B
2016 Q4 1,651 877 M $69.3 B
2016 Q3 1,656 879 M $78.3 B
2016 Q2 1,660 895 M $89.4 B
2016 Q1 1,635 927 M $93.4 B
2015 Q4 1,639 934 M $91.7 B
2015 Q3 1,582 938 M $90.5 B
2015 Q2 1,560 937 M $98.2 B
2015 Q1 1,527 941 M $97.2 B
2014 Q4 1,493 972 M $94.0 B
2014 Q3 1,361 972 M $77.4 B
2014 Q2 1,336 1.00 B $76.9 B
2014 Q1 1,300 995 M $74.9 B